![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Everolimus, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-367 - Rev 01
This Chemical Type CEP, issued on May 16, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2918 associated with this CEP further emphasizes